SCHEMBL536128

SCHEMBL536128

CCCCCCCCCCCCCCCCCC(=O)N[C@H](CCC(=O)O)C(=O)O.[NaH]

nearest known ligand 0.79

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 9/20 0.79
PLA2G2C Q5R387 1/20 0.65
PLA2G10 O15496 2/20 0.60
SLC6A5 Q9Y345 2/20 0.59
FAAH O00519 2/20 0.54
MEN1 O00255 1/20 0.54
MAPK1 P28482 1/20 0.54
KMT2A Q03164 1/20 0.54
FOLH1 Q04609 1/20 0.53
RIMKLA Q8IXN7 1/20 0.53
NAALAD2 Q9Y3Q0 1/20 0.53
EPHX2 P34913 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL872599 1.00 NOD1 (0.79) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL8728931 1.00 NOD1 (0.79) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL7942033 1.00 NOD1 (0.79) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL714530 1.00 NOD1 (0.79) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL6635175 1.00 NOD1 (0.79) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL20956609 1.00 NOD1 (0.79) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL20956606 1.00 NOD1 (0.79) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL20956594 1.00 NOD1 (0.79) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL20956593 1.00 NOD1 (0.79) NOD1PLA2G2CPLA2G10SLC6A5FAAH
SCHEMBL715201 1.00 NOD1 (0.79) NOD1PLA2G2CPLA2G10SLC6A5FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 445 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501777-B1 BROAD SPECTRUM UVA STABLE, NON-TOXIC, ZINC OXIDE BASED COMPLEX GRUNE GUERRY L (US) 2022-10-26 EP claimed
CN-110799169-A Cosmetic preparation 吉欧化工有限公司 2020-02-14 CN claimed
US-9320920-B2 Wax-in-water emulsion comprising a combination of a glutamic acid derivative and an alkylpolyglycoside L'OREAL (FR) 2016-04-26 US claimed
EP-1391193-B1 Silicone-in-water emulsion comprising specific polyether-polydimethylsiloxane copolymer BEIERSDORF AG (DE) 2007-01-03 EP claimed
JP-56036564-A None JP disclosed
JP-8163983-A None JP disclosed
WO-2026100477-A1 FIRE EXTINGUISHING COMPOSITION 花王株式会社 2026-05-15 WO disclosed
US-20260130832-A1 EMULSION COMPOSITION AJINOMOTO CO., INC. (JP) 2026-05-14 US disclosed
US-20260007586-A1 OIL-IN-WATER EMULSION-TYPE COSMETIC COMPOSITION SHISEIDO COMPANY, LTD. (JP) 2026-01-08 US disclosed
EP-4674404-A1 EMULSION COMPOSITION AJINOMOTO CO., INC. (JP) 2026-01-07 EP disclosed
US-20250381792-A1 METHOD FOR MANUFACTURING PRINTED MATTER, LAMINATE USING SAME, AND METHOD FOR MANUFACTURING PACKAGING BAG TORAY INDUSTRIES, INC. (JP) 2025-12-18 US disclosed
EP-4629965-A1 COSMETICAL AND PHARMACEUTICAL COMPOSITIONS CONTAINING BACILLUS STRAINS OR FERMENTATION BROTHS THEREOF Evonik Operations GmbH (DE) 2025-10-15 EP disclosed
EP-0364928-B1 Paste-like dentifrice composition AJINOMOTO KK (JP) 1994-04-06 EP disclosed
EP-0394470-B1 COMPOSITION FOR ORAL CAVITY SUNSTAR KABUSHIKI KAISHA (JP) 1993-06-16 EP disclosed
US-5108735-A Mutanase, non-ionic surfactant and either n-acyl sarcosinate or N-acyl glutamate SUNSTAR KABUSHIKI KAISHA (JP) 1992-04-28 US disclosed
EP-0394470-A1 COMPOSITION FOR ORAL CAVITY SUNSTAR KABUSHIKI KAISHA (JP) 1990-10-31 EP disclosed
EP-0364928-A2 Paste-like dentifrice composition AJINOMOTO CO., INC. (JP) 1990-04-25 EP disclosed
US-4606914-A N-ACYLAMINO ACID SALT MIYOSHI KASEI CO., LTD. (JP) 1986-08-19 US disclosed
JP-S5636564-A SOLID FINGER TIP WETTING AGENT FUEKI NORI KOGYO KK 1981-04-09 JP disclosed
US-4075830-A Solid adhesive compositions KONISHI CO., LTD. (JA) 1978-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260130832-A1 EMULSION COMPOSITION DGKA, DGKG, ADH1A NOD1 4630/4885PLA2G2C 951/4885PLA2G10 528/4885
US-20260007586-A1 OIL-IN-WATER EMULSION-TYPE COSMETIC COMPOSITION CUTA, LIPA, LRBA NOD1 3930/4885PLA2G2C 111/4885PLA2G10 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.